JUL 16, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Fabhalta (Efficacy)
U.S. Food and Drug Administration
FDA supplemental approval for expanded indication or new efficacy claim; regulatory action without trial outcome data in this record.
Reported
Approval date2026-07-16
Active ingredient dose200 mg base